Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - Goldman Sachs initiated coverage on Uranium Energy Corp (NYSE:UEC) with a Buy rating and a price target of $13.00, implying approximately 30% upside potential. The stock, currently trading near its 52-week high of $10.36, has delivered an impressive 126% return over the past year.
The investment bank views UEC as a pure-play, US-based uranium mining company that is advancing a portfolio of assets capable of ramping to several million pounds of production capacity in the medium term.
Goldman Sachs highlighted that UEC possesses the largest licensed processing capacity within the United States, maintains a debt-free balance sheet, and remains leveraged to potentially higher pricing within the nuclear fuel supply chain, particularly for triuranium octoxide (U3O8).
The firm emphasized that nuclear energy demand is poised for significant growth in the US, positioning UEC’s domestic operations as a key competitive advantage.
Goldman Sachs believes this domestic position could drive scarcity value in an environment where policy support and potential investment into critical minerals across key industries, including nuclear, are gaining momentum and driving structural market shifts.
In other recent news, Uranium Energy Corp announced that stockholders approved all proposals at its annual general meeting, including the election of six directors and the appointment of PricewaterhouseCoopers LLP as the independent registered accounting firm. The company also increased its stake in Anfield Energy to 32.4% by acquiring 170 million common shares. This move could potentially increase Uranium Energy’s influence in Anfield, as the company would control about 37.6% on a partially diluted basis. Additionally, Uranium Energy’s Sweetwater Complex received a FAST-41 transparency project designation from the Federal Permitting Improvement Steering Council, following a March 2025 Executive Order aimed at boosting domestic mineral production.
Analysts have shown interest in Uranium Energy, with Stifel reiterating a Buy rating and a $10.50 price target, citing the recent designation as a positive development. BMO Capital also initiated coverage with an outperform rating, setting a price target of $7.75, and noted the company’s strategic position as a U.S.-listed uranium producer. BMO Capital highlighted Uranium Energy’s "hub and spoke" development model, which is known for its low capital intensity and is expected to provide production and funding flexibility. These developments come as the nuclear energy sector experiences renewed interest, with Uranium Energy positioned to potentially benefit from this trend.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.